MorphoSys

Germany
Bayern, Germany, Planegg
+49 89 899270 ★

Company profile

MorphoSys company profile

MorphoSys AG is a biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next generation of antibodies, which can be used to treat diseases and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceutical and biotechnology sectors, such as Boehringer Ingelheim, Daiichi Sankyo, Merck & Co, Novartis, Pfizer, and Roche.

Business identity

Contact email
[email protected]
Phone number
+49 89 899270
Operating status
Active
Company type
For Profit
Employee range
00501-01000 employees
Revenue range
$100K+
Founded
1992-01-01

Headquarters

Headquarters
Bayern, Germany, Planegg
Postal code
82152
Country code
DE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
5
Total equity funding
$366.5M
Last funding
Post Ipo Equity / $112.9M / 2023-12-14
Last equity funding
Post Ipo Equity / $112.9M
Investors
1
Founders
2
Articles
321
Exited on
1999-03-09

Founders and investors

Founders

Andreas PluckthunSimon E. Moroney

Investors

Atlas Venture

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.